These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25770775)

  • 1. Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy.
    Mukker JK; Singh RS; Derendorf H
    Adv Drug Deliv Rev; 2015 May; 85():57-64. PubMed ID: 25770775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs.
    Matera MG; Calzetta L; Ora J; Rogliani P; Cazzola M
    Expert Opin Drug Deliv; 2021 Jul; 18(7):891-906. PubMed ID: 33412922
    [No Abstract]   [Full Text] [Related]  

  • 3. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
    Andes D; Anon J; Jacobs MR; Craig WA
    Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in inhaled product development and opportunities for open innovation.
    Forbes B; Asgharian B; Dailey LA; Ferguson D; Gerde P; Gumbleton M; Gustavsson L; Hardy C; Hassall D; Jones R; Lock R; Maas J; McGovern T; Pitcairn GR; Somers G; Wolff RK
    Adv Drug Deliv Rev; 2011; 63(1-2):69-87. PubMed ID: 21144875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of pharmacokinetic/pharmacodynamic modelling and simulation for the prediction of target attainment of ceftobiprole against meticillin-resistant Staphylococcus aureus using minimum inhibitory concentration and time-kill curve based approaches.
    Barbour AM; Schmidt S; Zhuang L; Rand K; Derendorf H
    Int J Antimicrob Agents; 2014 Jan; 43(1):60-7. PubMed ID: 24183800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile analyses for inhaled drugs in humans using the lung delivery and disposition model.
    Raut A; Dhapare S; Venitz J; Sakagami M
    Biopharm Drug Dispos; 2020 Feb; 41(1-2):32-43. PubMed ID: 31691979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic modelling of the bactericidal activity of free lung concentrations of levofloxacin and gatifloxacin against Streptococcus pneumoniae.
    Tasso L; de Andrade C; Dalla Costa T
    Int J Antimicrob Agents; 2011 Oct; 38(4):307-13. PubMed ID: 21802907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions.
    Caniga M; Cabal A; Mehta K; Ross DS; Gil MA; Woodhouse JD; Eckman J; Naber JR; Callahan MK; Goncalves L; Hill SE; Mcleod RL; McIntosh F; Freke MC; Visser SA; Johnson N; Salmon M; Cicmil M
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):362-77. PubMed ID: 26859446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies.
    d'Angelo I; Conte C; La Rotonda MI; Miro A; Quaglia F; Ungaro F
    Adv Drug Deliv Rev; 2014 Aug; 75():92-111. PubMed ID: 24842473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
    Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia.
    Fish DN; Kiser TH
    Pharmacotherapy; 2013 Oct; 33(10):1022-34. PubMed ID: 23744833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.
    Selting K; Waldrep JC; Reinero C; Branson K; Gustafson D; Kim DY; Henry C; Owen N; Madsen R; Dhand R
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):255-68. PubMed ID: 18759657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of inhaled antimicrobials.
    Stockmann C; Roberts JK; Yellepeddi VK; Sherwin CM
    Clin Pharmacokinet; 2015 May; 54(5):473-92. PubMed ID: 25735634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposure.
    Wu B; Derendorf H
    Pharmazie; 2010 Jun; 65(6):417-20. PubMed ID: 20614689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of antibiotic treatment in surgical infections of the abdomen. Pharmacokinetic basis for short courses of antimicrobial therapy.
    Wittmann DH
    Eur J Surg Suppl; 1996; (576):19-23. PubMed ID: 8908464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.